Thoracic Tumours Register

Thoracic Tumors Clinical Trial

— RTT  

Official title:

Thoracic Tumours Register

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT02941458
• Other study ID #: GECP 16/01_RTT
• Status: Recruiting
• Start date: July 21, 2016
• Est. completion date: December 30, 2030

Study information

• Verified date: January 2024
• Source: Spanish Lung Cancer Group
• Contact: Eva Pereira
• Phone: +34934302006
• Email: epereira[@]gecp.org
• Is FDA regulated: No
• Study type: Observational [Patient Registry]

Clinical Trial Summary

Observational, multicenter study in patients with lung cancer and other thoracic tumors.

The GECP, in its commitment to improve the treatment and prognosis of patients with lung cancer and other thoracic tumors, has marked the individualization of treatment according to the expression of markers predictive of response to chemotherapeutic agents and molecular inhibitors of cell proliferation as one of its primary objectives. This could significantly improve the prognosis of patients with lung cancer, and will lead to a radical change in routine clinical practice. The aim of the register is to explore all data available of all patients treated because of thoracic tumours.

Description:

Observational, multicenter study in patients with lung cancer and other thoracic tumors. In a prospective and retrospective way, information will be obtained from the clinical history of each patient.

In Europe, patients with lung cancer have a poor prognosis, and there has been only limited improvement between 1999 and 2007. Potential advantages of the centralization of care and the discussion of treatment strategies in multidisciplinary teams, as suggested in other studies,13 require further research. However, the priorities should be to prevent lung cancer by implementing anti-smoking policies and controlling asbestos exposure throughout Europe, such as was recommended by the World Health Organization (WHO) in 2008.14 Other priorities are to reduce levels of residential radon in risk areas, and early diagnosis to improve the results of surgery, which is still the main curative treatment.

The variability in the diagnostic process, treatment and advocacy, as well as the anticipated increase in associated mortality in Spain in coming years, has stimulated the creation of an epidemiological, observational, multicenter study of cases of lung cancer and other thoracic tumors diagnosed and treated by medical personnel, including both thoracic surgeons and medical oncologists. Data from this study will be collected retrospectively and prospectively, so as to enable an extensive study of the epidemiological and therapeutic factors related to the disease.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 10000
• Est. completion date: December 30, 2030
• Est. primary completion date: December 30, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Patients with thoracic disease, treated with an active treatment or not treated (only palliative care)

Exclusion Criteria:

• Patients with other type of tumours

Related Conditions & MeSH terms

• Thoracic Neoplasms
• Thoracic Tumors

Locations

Country	Name	City	State
Spain	Complejo Hospitalario Universitario de Albacete	Albacete
Spain	Hospital Príncipe de Asturias	Alcalá De Henares	Madrid
Spain	Hospital General La Mancha Centro	Alcázar De San Juan	Ciudad Real
Spain	Hospital Universitario Fundación Alcorcón	Alcorcón	Madrid
Spain	H. Virgen de los Lirios	Alcoy	Alicante
Spain	Hospital General de Alicante	Alicante
Spain	H. Germans Trias i Pujol	Badalona	Barcelona
Spain	Hospital de La Santa Creu I Sant Pau	Barcelona
Spain	Hospital de Basurto	Bilbao	Vizcaya
Spain	Hospital de Burgos	Burgos
Spain	Hospital San Pedro de Alcántara	Cáceres
Spain	Hospital General Universitario Santa Lucía	Cartagena	Murcia
Spain	H. Provincial de Castellón	Castelló
Spain	Hospital General Universitario de Ciudad Real	Ciudad Real
Spain	Hospital Virgen de la Luz	Cuenca
Spain	Hospital de Elche	Elche	Alicante
Spain	Hospital General de Elda	Elda	Alicante
Spain	Complejo Hospitalario Universitario de Ferrol	Ferrol	A Coruña
Spain	H. Fuenlabrada	Fuenlabrada	Madrid
Spain	Hospital Dr. Josep Trueta	Girona
Spain	H. Virgen de las Nieves	Granada
Spain	Oncogranada	Granada
Spain	Hospital de Jaén	Jaén
Spain	Complejo Hospitalario de la Coruña	La Coruña	Coruña
Spain	H. Universitario de Canarias	La Laguna	Tenerife
Spain	H. Insular de Gran Canarias	Las Palmas De Gran Canaria	Gran Canarias
Spain	Complejo Asistencial Universitario de León	León
Spain	Hospital Universitario Lucus Augusti	Lugo
Spain	Fundación Jimenez Diaz	Madrid
Spain	H. Clínico San Carlos	Madrid
Spain	H. La Paz	Madrid
Spain	H.U. Puerta de Hierro	Madrid
Spain	Hospital General Universitario Gregorio Marañón	Madrid
Spain	Hospital La Princesa	Madrid
Spain	Hospital Universitario Infanta Sofía	Madrid
Spain	Hospital Universitario Sanchinarro	Madrid
Spain	Imoncology	Madrid
Spain	H. Carlos Haya	Málaga
Spain	Hospital Quirón Salud Málaga	Málaga
Spain	Hospital Virgen de la Victoria	Málaga
Spain	Hospital de Mataró	Mataró	Barcelona
Spain	Hospital Universitario de Móstoles	Móstoles	Madrid
Spain	H. Morales Messeguer	Murcia
Spain	Hospital Clínico Universitario Virgen de la Arrixaca	Murcia
Spain	Hospital Santa María Naí	Ourense
Spain	Hospital Son Espases	Palma de Mallorca
Spain	Clínica Universitaria de Navarra	Pamplona	Navarra
Spain	Complejo Hospitalario de Navarra	Pamplona	Navarra
Spain	Hospital Universitario Infanta Cristina	Parla	Madrid
Spain	Hospital Universitario Quirón Madrid	Pozuelo De Alarcón	Madrid
Spain	Hospital Sant Joan de Reus	Reus	Tarragona
Spain	Hospital Clinico de Salamanca	Salamanca
Spain	H. de Donostia	San Sebastian
Spain	Hospital Nuestra Señora Candelaria	Santa Cruz de Tenerife
Spain	Hospital Virgen del Rocío	Sevilla
Spain	Hospital Sant Pau i Santa Tecla	Tarragona
Spain	Consorci Sanitari de Terrassa	Terrassa	Barcelona
Spain	Hospital Virgen de la Salud	Toledo
Spain	Hospital Verge de la Cinta	Tortosa	Tarragona
Spain	Hospital Reina Sofía	Tudela	Navarra
Spain	H. Arnau de Vilanova Valencia	Valencia
Spain	H. General U. de Valencia	Valencia
Spain	Hospital Dr. Peset	Valencia
Spain	Hospital La Fe	Valencia
Spain	Instituto Valenciano de Oncología	Valencia
Spain	Hospital Clínico Universitario de Valladolid	Valladolid
Spain	Complejo Hospitalario de Vigo	Vigo	Pontevedra
Spain	Hospital Universitario de Áraba	Vitoria	Áraba
Spain	Hospital Lluís Alcanyís	Xàtiva	Valencia
Spain	Complejo Asistencial de Zamora	Zamora

Sponsors (1)

Lead Sponsor	Collaborator
Spanish Lung Cancer Group

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Describe epidemiology characteristics of lung cancer and other thoracic tumors in Spanish people	To know the epidemiology characteristics of lung cancer and other thoracic tumors in Spain, as well as clinical and histological data, diagnosis, treatments received, and prognostic factors	up to 10 years

External Links

•   Related Info